Search

Search Constraints

You searched for: Author/Creator Cwynarski, Kate

Search Results

4. A national service for delivering CD19 CAR‐Tin large B‐cell lymphoma – The UK real‐world experience. (29th April 2022)

5. A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL. Issue 4 (9th September 2019)

6. A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphoma. Issue 9 (September 2013)

7. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy. (15th May 2015)

8. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy. (15th May 2015)

10. Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. (12th March 2018)